PPMD welcomes Dr. Padraig Wright from GlaxoSmithKline as our guest for a webinar on February 22, 2012 at 1pm eastern.
Topic: Exon Skipping
When: Wednesday, February 22, 1pm eastern
GSK2402968 is an antisense oligonucleotide being developed by GlaxoSmithKline as a potential treatment for boys with Duchenne who have mutations/deletions that can be treated with exon 51 “skipping.” This pr…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this